Prognia
Drug Database
🇺🇸US · FDA ApprovedPrescriptionNDA022290-001

ADREVIEW(IOBENGUANE SULFATE I-123)

Manufacturer: GE HEALTHCARE

FDA Approval: 19/09/2008

Route: INTRAVENOUS · SOLUTION

Active Ingredients

IOBENGUANE SULFATE I-123 10mCi/5ML (2mCi/ML)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ADREVIEW — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.